NEWTON, Mass., July 24, 2026 (GLOBE NEWSWIRE) -- Magnendo Corp., an MIT spinout developing magnetic robotic navigation technology for neuro-endovascular intervention, today announced the closing of an $18 million Series A financing led by Penumbra, Inc., the world’s leading thrombectomy company, with participation from a syndicate of new and existing institutional investors.

马萨诸塞州牛顿市，2026年7月24日（环球社讯）——Magnendo Corp.，一家从麻省理工学院分拆出来、致力于开发用于神经血管介入治疗的磁控机器人导航技术的公司，今日宣布完成1800万美元的A轮融资。本轮融资由全球领先的血栓切除器械公司Penumbra, Inc.领投，并有多家新老机构投资者组成的银团参与投资。

The financing will support the productization of Magnendo's robotic platform and preparation for first-in-human clinical studies..

这笔融资将支持Magnendo机器人平台的产品化，并为首次人体临床研究做好准备。

Mechanical thrombectomy has transformed the treatment of acute ischemic stroke, yet rapidly reaching the treatment site remains one of the most technically demanding and time-sensitive aspects of the procedure. Navigating from the vascular access site to the clot through complex and often highly tortuous patient anatomy continues to be a major procedural bottleneck, contributing to prolonged procedure times and poorer outcomes in a significant percentage of patients..

机械取栓术已彻底改变急性缺血性卒中的治疗格局，然而快速抵达治疗部位仍是该手术中技术难度最高、对时间最敏感的环节之一。从血管入路部位穿行至血栓处，需经过复杂且常高度迂曲的患者血管解剖结构，这依然是手术的主要瓶颈，导致相当比例患者的手术时间延长且预后不良。

Magnendo is developing a robotic system that combines magnetically steerable guidewires with robotic control, advanced medical imaging, and intelligent navigation software to improve endovascular access. The system is designed to help physicians navigate complex vascular anatomy more quickly, consistently, and reliably while remaining compatible with existing clinical workflows and commercially available devices..

Magnendo 正在开发一种机器人系统，该系统将磁控导丝与机器人控制、先进医学成像和智能导航软件相结合，以改善血管内介入通路。该系统旨在帮助医生更快速、更一致且更可靠地 navigating 复杂的血管解剖结构，同时保持与现有临床工作流程及市售设备的兼容性。

The company has demonstrated encouraging preclinical results in collaboration with leading neurointerventional physicians, showing the potential to substantially reduce navigation times while improving procedural consistency across operators and anatomies. The proceeds from the Series A financing will support the productization of Magnendo's preclinically validated robotic system and magnetic guidewires and advance the company’s first clinical platform toward first-in-human studies..

该公司在与领先的神经介入医师合作中展示了令人鼓舞的临床前结果，显示出在提高不同操作者和解剖结构下的手术一致性的同时，大幅缩短导航时间的潜力。A轮融资所得资金将用于推动Magnendo经临床前验证的机器人系统和磁性导丝的产品化，并推进公司首个临床平台进入首次人体研究阶段。

'Our mission is to redefine endovascular access through magnetic robotic navigation, enabling physicians to reach the treatment site faster, more reliably, and with greater consistency,' said Yoonho Kim, Ph.D., Founder and CEO of Magnendo. 'This financing enables us to accelerate the productization of our preclinically validated platform and prepare for first-in-human studies.

“我们的使命是通过磁控机器人导航技术重新定义血管内介入通路，使医生能够更快、更可靠且更一致地到达治疗部位，”Magnendo 创始人兼首席执行官 Yoonho Kim 博士表示。“这笔融资将使我们能够加速经过临床前验证的平台的产业化进程，并为首次人体研究做好准备。”

We are grateful for Penumbra's confidence in our team and look forward to bringing this technology closer to physicians and patients.'.

我们感谢Penumbra对我们团队的信任，并期待将这项技术更紧密地带给医生和患者。

'Magnendo has developed an elegant and pragmatic approach to one of the most challenging aspects of endovascular intervention,' said Shruthi Narayan, President of Penumbra. 'We believe the company's focus on improving navigation while integrating into existing clinical workflows has the potential to meaningfully advance neurovascular care, and we are excited to support the team as they move toward clinical translation.'.

Penumbra总裁Shruthi Narayan表示：“Magnendo为血管内介入治疗中最具挑战性的环节之一，开发出了一套优雅而务实的解决方案。我们相信，该公司在融入现有临床工作流程的同时专注于提升导航性能，有望显著推动神经血管疾病诊疗的进步。我们很高兴在其迈向临床转化的过程中提供支持。”

About Magnendo

关于 Magnendo

Magnendo Corp. is an MIT spinout developing magnetic robotic navigation technology for endovascular intervention. By combining magnetically steerable guidewires with advanced robotics, medical imaging, and intelligent navigation software, Magnendo aims to help physicians reach the treatment site faster, more reliably, and with greater consistency.

Magnendo公司是一家源自麻省理工学院的衍生企业，致力于开发用于血管内介入治疗的磁性机器人导航技术。通过将磁控导丝与先进机器人技术、医学影像以及智能导航软件相结合，Magnendo旨在帮助医生更快速、更可靠且更一致地到达治疗部位。

Its mission is to make life-saving endovascular procedures faster, safer, and more accessible for every patient. For more information, visit .

其使命是让挽救生命的血管内手术对每位患者而言更快速、更安全、更易获得。欲了解更多信息，请访问。

www.magnendo.com

www.magnendo.com

or connect on

或在以下平台联系

LinkedIn

领英

.

。

About Penumbra

关于半影

Penumbra, Inc., the world’s leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity.

Penumbra, Inc. 是全球领先的血栓切除术公司，专注于为缺血性卒中、静脉血栓栓塞症（如肺栓塞）以及急性肢体缺血等具有挑战性的医疗状况开发最具创新性的技术。我们广泛的产品组合以计算机辅助真空血栓切除术（CAVT）为核心，致力于以快速、安全且简便的方式清除全身各部位的血栓。

By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit .

通过开创这些创新，我们支持100多个国家的医疗保健提供者、医院和诊所，致力于改善患者治疗效果和生活质量。欲了解更多信息，请访问。

www.penumbrainc.com

www.penumbrainc.com

and connect on

并连接至

Instagram

Instagram

,

，

LinkedIn

领英

, and

，以及

X

X

.

。

Contacts

联系人

Media:

媒体：

info@magnendo.com

info@magnendo.com